USP22 and melanoma: Inactivation of ubiquitin-specific peptidase 22 (USP22), a deubiquitinating protease, reduced the sensitivity of melanoma cells to T cell-mediated killing by regulating the IFN-JAK1-STAT1 signaling pathway [23].